hVIVO (DUB:HVO) Days Payable : 11.66 (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is hVIVO Days Payable?

hVIVO's average Accounts Payable for the six months ended in Jun. 2024 was €2.15 Mil. hVIVO's Cost of Goods Sold for the six months ended in Jun. 2024 was €33.64 Mil. Hence, hVIVO's Days Payable for the six months ended in Jun. 2024 was 11.66.

The historical rank and industry rank for hVIVO's Days Payable or its related term are showing as below:

DUB:HVO' s Days Payable Range Over the Past 10 Years
Min: 20.8 Med: 697.37 Max: 819.83
Current: 20.8

During the past 13 years, hVIVO's highest Days Payable was 819.83. The lowest was 20.80. And the median was 697.37.

DUB:HVO's Days Payable is ranked worse than
89.32% of 721 companies
in the Biotechnology industry
Industry Median: 135.97 vs DUB:HVO: 20.80

hVIVO's Days Payable declined from Jun. 2023 (15.51) to Jun. 2024 (11.66). It may suggest that hVIVO accelerated paying its suppliers.

hVIVO Days Payable Historical Data

The historical data trend for hVIVO's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Days Payable Chart

hVIVO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

706.14

793.63

35.97

hVIVO Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															141.86	-	15.51	426.12	11.66

Competitive Comparison of hVIVO's Days Payable

For the Biotechnology subindustry, hVIVO's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

hVIVO's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, hVIVO's Days Payable distribution charts can be found below:

* The bar in red indicates where hVIVO's Days Payable falls into.

hVIVO Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

hVIVO's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.106	+	2.424)	/	2 )	/	28.055	*	365
=	2.765					/	28.055	*	365
=	35.97

hVIVO's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (2.424	+	1.873)	/	2 )	/	33.637	*	365 / 2
=	2.1485					/	33.637	*	365 / 2
=	11.66

hVIVO Days Payable Related Terms

Thank you for viewing the detailed overview of hVIVO's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (DUB:HVO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ORPH:UK HVO:UK CRO:Germany

Address

42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.hvivo.com

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

No Headlines